Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
29 May 2020

RETURN OF STAFF AND STUDENTS TO ALL CAMPUSES AS FROM 1 JUNE 2020

Message by Prof Francis Petersen, Rector and Vice-Chancellor

Dear Colleagues,

I hope that you are well, healthy, and safe. Since my last message to you, President Cyril Ramaphosa has announced that our country will move to Level 3 of the national lockdown on 1 June 2020. Subsequently, Dr Blade Nzimande, Minister of Higher Education, Science and Innovation, announced specific measures for the post-school education sector in response to the COVID-19 epidemic under Level 3, in order to re-integrate staff and students on campus.  

Over the past few weeks, a tremendous amount of work has been done to ensure the continuation of the Academic Project, and to prepare our campuses for the return of staff and students, ensuring that it is aligned with national directives and protocols. This was no small task. In a crisis, we have to do more than expected, and we have to go beyond the call of duty. During the past two months, I have seen and experienced many instances where multi-functional teams effectively engaged to ensure the continuity of the Academic Project, and the ongoing functioning of the university’s operations. I am immensely proud of what has been achieved so far.

The impact of the COVID-19 pandemic has forced us to explore and implement many innovative ways to ensure sustainability and survival. The university management followed a risk-based approach in devising a plan to continue providing tuition and academic activities to students during this time, and to complete the 2020 academic year. Over and above this, we have ensured that our campuses are ready for the return of staff and students from 1 June 2020. In our planning, a phased-in approach is followed to limit the number of staff and students present at a single location at any given time. This is in line with the national directive that a maximum of 33% of the university’s staff and student population may be allowed on campus during Level 3 of the national lockdown.

The Special Executive Group (SEG), which I chair, and which was established at the beginning of March 2020, continues to meet weekly to discuss and decide on the university’s response to COVID-19 as this pandemic develops over time. Consisting of a number of task teams, the SEG is the decision-making entity that responds rapidly, and in a coordinated manner to combat the threats to business continuity. It also identifies opportunities where the intellectual knowledge base of the university could be utilised to impact society positively.

As from 1 June 2020, all staff members – except those categories of staff specifically mentioned in the re-integration plan – will continue working from home during Level 3, until such time as they are officially informed by their line managers to return to work. However, staff members may be expected to return to work during this period if the situation so requires. Staff members must therefore be available and contactable by their line managers at all times during normal UFS working hours.

Staff members returning to campus as from 1 June 2020 will include academic staff who support and lecture our returning students, as well as support staff in specifically identified business areas. I want to assure you that your safety, health, and well-being remain our first priority when you return to campus. Teams from University Estates and other business areas have worked tirelessly over the past weeks to prepare the campuses. This includes the disinfection and deep cleaning (where necessary) of open areas and the hygienic preparation of the campuses (e.g. hand sanitisers, hand-washing stations at, for instance, entrance gates and areas with high pedestrian traffic, Perspex screens installed in high-traffic reception areas where face-to-face engagement is needed, and social distancing markers in high-traffic buildings). Similarly, lecture halls are also being prepared to ensure social/physical distancing.  

Strict access protocols will be maintained at the campus entrances during Level 3 of the national lockdown. Only staff and students authorised to return to the campuses and issued with authorisation letters will be granted access to the campuses. The wearing of masks is compulsory when entering the campuses and proof of screening must be provided. An online screening questionnaire has been designed for this purpose. These measures will help ensure that it is safe for staff and students to return to our campuses. 

Residences on the three campuses are currently being prepared to receive students. This includes the installation of hand-sanitiser stations at the entrances of buildings and maintaining social/physical distancing in the general areas. Daily screening of students in residences will be compulsory.

I am attaching a document that explains the re-integration plan for Level 3 in detail, including the arrangements for the return of staff and students to our campuses: the categories of staff and students, entry to the campus, wearing of cloth masks, social distancing, environmental hygiene, protocol for on-campus meetings, vulnerable members of staff, staff with minor children, public transport, and the management of visitors during this period. The plan will be amended as and when needed. 

It is important that you maintain regular contact with your team and fellow colleagues. Most of our staff has been working from home for more than two months, and I know you might be missing the collegiality and campus environment. I want to encourage you to be patient, to look after your physical and mental health, and to make use of the resources available from the Department of Human Resources.

COVID-19 has provided us with opportunities to rethink the world of higher education afresh, and its impact has been transformative and forced us to think beyond the pandemic.

May you have a good and restful weekend – remember to #StayAtHome.

Regards,
Prof Francis Petersen
Rector and Vice-Chancellor

News Archive

Research contributes to improving quality of life for cancer patients
2016-11-21

Description: Inorganic Chemistry supervisors Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept